In-Depth Examination Of 6 Analyst Recommendations For Evolent HealthBenzinga • 7 days ago
Latest Ratings for EVH
DateFirmActionFromTo Nov 2021JP MorganUpgradesNeutralOverweight Aug 2021Canaccord GenuityMaintainsBuy Mar 2021Canaccord GenuityMaintainsBuy
View More Analyst Ratings for...
Share to Feed
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 PR Newswire WASHINGTON, April 18...
Evolent Health (NYSE:EVH - Free Report) had its target price cut by Canaccord Genuity Group from $45.00 to $44.00 in a research report report published on Thursday, Benzinga reports. They currently...
Evolent Health, Inc. (NYSE:EVH Get Free Report) has received an average rating of Moderate Buy from the twelve analysts that are presently covering the stock, Marketbeat.com...
Latest Ratings for EVH
DateFirmActionFromTo Nov 2021JP MorganUpgradesNeutralOverweight Aug 2021Canaccord GenuityMaintainsBuy Mar 2021Canaccord GenuityMaintainsBuy
View More Analyst Ratings for...
Northern Trust Corp boosted its stake in shares of Evolent Health, Inc. (NYSE:EVH Free Report) by 2.5% in the 3rd quarter, according to the company in its most recent disclosure with the...
Kennedy Capital Management LLC boosted its stake in Evolent Health, Inc. (NYSE:EVH Free Report) by 6.2% in the third quarter, according to the company in its most recent 13F filing with the...
This is a signal that EVH's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Truist Financial analyst Jailendra Singh assigned a Hold rating to the stock today. The company's shares closed yesterday at $34.72. According to T...
This is a signal that EVH's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...